Preliminary analysis of combined romosozumab and denosumab versus teriparatide and denosumab on bone mineral density
Both combination therapies effectively improve lumbar spine BMD over 6 months. The ROMO + Dmab regimen yielded numerically greater increases with fewer injections.
Authors
- Tzu-Hao Tseng (ORCID: https://orcid.org/0000-0002-8564-3149)
- Ming-Hung Chiang (ORCID: https://orcid.org/0000-0002-0887-7718)
- Hung‐Kuan Yen (ORCID: https://orcid.org/0000-0003-4381-2220)
- Chia‐Che Lee (ORCID: https://orcid.org/0000-0002-1616-0178)
- Tian-Sin Fan (ORCID: https://orcid.org/0000-0001-9045-8063)
- Yi-Chien Lu (ORCID: https://orcid.org/0000-0002-3992-2489)
- Shau‐Huai Fu (ORCID: https://orcid.org/0000-0001-9853-872X)
- Chih‐Chien Hung (ORCID: https://orcid.org/0000-0001-6523-9520)
- Chen‐Yu Wang (ORCID: https://orcid.org/0000-0003-0498-2438)
- Ning-Huei Sie (ORCID: https://orcid.org/0009-0003-0731-1880)
Institutions
- National Chung Cheng University (TW)
- National Health Research Institutes (TW)
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Osteoporosis and Sarcopenia
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1016/j.afos.2025.11.002
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00